Zingiber officinale — ginger — has been used in medicine and cooking across Asia, the Middle East, and the Mediterranean for at least 5,000 years. It appears in ancient Indian Ayurvedic texts, Chinese medical classics, and Greek and Roman writings. The World Health Organization has recognized ginger as a traditional medicine with significant clinical evidence. Thousands of peer-reviewed studies have characterized its pharmacology, and multiple randomized controlled trials have validated specific clinical applications.
Key Active Compounds
Gingerols
Gingerols are the primary bioactive compounds in fresh ginger. The most abundant is 6-gingerol, which demonstrates anti-inflammatory, antioxidant, antiemetic, analgesic, and anticancer properties in research. Gingerols inhibit COX-2 and lipoxygenase (LOX) — two key inflammatory enzymes — through mechanisms that parallel NSAIDs without the gastrointestinal toxicity.
Shogaols
When ginger is dried or cooked, gingerols are converted to shogaols — compounds that are generally more potent than their gingerol precursors in pharmacological activity. 6-shogaol has shown particularly strong anti-cancer and neuroprotective activity in preclinical research. Dried ginger extract and standardized shogaol preparations capture this enhanced activity.
Zingerone and Paradols
Additional bioactive compounds including zingerone (from cooked ginger) and paradols contribute to ginger's overall pharmacological profile, particularly in antioxidant and anti-inflammatory activity.
Clinical Evidence
Nausea: The Strongest Evidence
Ginger's antiemetic properties are among the best-supported in botanical medicine. A 2014 review of 12 randomized controlled trials found ginger to be superior to placebo for pregnancy-related nausea and equivalent to vitamin B6, with a much better safety profile than antiemetic medications for this indication. The mechanism involves 5-HT3 receptor antagonism — the same pathway targeted by pharmaceutical antiemetics like ondansetron — as well as muscarinic receptor antagonism and gastric motility enhancement.
For chemotherapy-induced nausea, a 2012 multi-site Phase II/III clinical trial sponsored by the National Cancer Institute found that 0.5g or 1.0g of ginger significantly reduced acute nausea in 644 cancer patients receiving chemotherapy, compared to placebo.
Osteoarthritis Pain
Multiple randomized controlled trials have demonstrated ginger's efficacy in osteoarthritis pain. A 2015 meta-analysis in Osteoarthritis and Cartilage found that ginger supplementation significantly reduced pain and disability compared to placebo in knee osteoarthritis, with effect sizes clinically meaningful. The dual COX-2/LOX inhibition provides a broader anti-inflammatory mechanism than NSAIDs, which primarily target COX enzymes.
Blood Sugar and Diabetes
A 2015 randomized controlled trial in the Journal of Complementary and Integrative Medicine found that 1600mg ginger per day significantly improved fasting blood glucose, HbA1c, insulin sensitivity, and lipid profiles in type 2 diabetes patients over 12 weeks. Multiple subsequent trials have replicated the glycemic effects, with meta-analyses confirming the signal.
Menstrual Pain
A 2009 double-blind randomized trial published in the Journal of Alternative and Complementary Medicine found ginger to be as effective as ibuprofen and mefenamic acid for primary dysmenorrhea — menstrual cramps — a finding that has been replicated in multiple subsequent trials. The COX-2 and prostaglandin inhibition mechanism directly addresses the pathophysiology of dysmenorrhea.
I run a clinical nutrition practice and ginger is in my top five most versatile tools. The nausea data is impeccable, the arthritis data is solid, and the glucose data is increasingly compelling. What I also appreciate is that I can pair it with curcumin and get documented synergistic anti-inflammatory effects — there's COX-2 plus LOX inhibition working together in a way neither provides alone. — Clinical nutritionist, Austin, TX
Synergy with Turmeric and Black Pepper
The traditional Ayurvedic combination of turmeric, ginger, and black pepper reflects an empirical recognition of synergy that modern pharmacology supports mechanistically. Ginger's LOX inhibition complements turmeric's COX-2 inhibition, covering both major inflammatory enzyme pathways. Black pepper's piperine enhances the bioavailability of both curcumin and gingerols. This three-herb combination represents one of the most clinically coherent anti-inflammatory botanical formulations.